Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | De Groot, J. F.; Cloughesy, T. F.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; Sulman, E. P.; Weller, M.; Wen, P. Y.; Hyddmark, E. M. V.; Mikkelsen, T.; Owen, S. P.; Mason, W. P.; Drappatz, J.; Blondin, N. A.; Perry, J. R.; GBM AGILE Investigators |
| Abstract Title: | Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400368 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.2005 |
| Notes: | Meeting Abstract: 2005 -- Source: Wos |
